Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Tucatinib and Trastuzumab for Patients with Advanced Solid Tumors with HER2 Changes

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium Germany Spain
  • Study of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Bulgaria France Italy Poland
  • Study of Futibatinib for Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Poland Portugal Spain
  • Study of Durvalumab and Tremelimumab with Y-90 SIRT Therapy for Patients with Advanced Intrahepatic Biliary Tract Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Study on the Effectiveness and Safety of Gemcitabine, Cisplatin, Trastuzumab, and Pembrolizumab for Untreated HER2-Positive Biliary Tract Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study on the Effects of Volrustomig and Drug Combination for Patients with Advanced Hepatobiliary Cancer

    Not recruiting

    2 1 1 1
    Italy Spain
  • Study on the Safety of LSTA1 with Standard Care for Patients with Advanced Head and Neck Cancer or Cholangiocarcinoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Spain
  • Study on Preoperative Treatment with Gemcitabine, Cisplatin, Durvalumab, and Tremelimumab for Patients with Intrahepatic Cholangiocarcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany